Dudediligence.

Azitra, Inc

AZTRAMEX · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$0.00Sep ’24$0.00Dec ’24$0.00Jun ’25$0.00Sep ’25$0.00Dec ’25
Net income, by quarter
−$1.0MSep ’24−$2.4MDec ’24−$3.1MMar ’25−$2.9MJun ’25−$2.8MSep ’25−$2.2MDec ’25−$3.9MMar ’26−$3.3MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenuenone on file$284,000$686,000$7,500$0.00
Operating incomenone on file−$9.5M−$7.5M−$11.0M−$11.0M
Net incomenone on file−$10.7M−$11.3M−$9.0M−$11.0M
Operating cash flownone on file−$8.3M−$7.4M−$10.2M−$11.2M
Free cash flownone on file−$8.4M−$7.4M−$10.2M−$11.2M
Cash$8.0M$3.5M$1.8M$4.6M$2.1M
Shares outstandingnone on file1.0M403.2K1.1M10.7M